Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of NRG1 mRNA | increases expression | 19933214
|
C488185 |
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide |
NRG1 protein alternative form inhibits the reaction [2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 15231676
|
C488185 |
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide |
NRG1 protein alternative form inhibits the reaction [2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide results in decreased phosphorylation of and results in decreased activity of MAPK3 protein] | decreases activity|decreases phosphorylation|decreases reaction | 15231676
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of NRG1 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of NRG1 mRNA | affects expression | 21346803
|
C019499 |
2-nitrofluorene |
2-nitrofluorene results in increased expression of NRG1 mRNA | increases expression | 14600272 15890375
|
C016583 |
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NRG1 mRNA | increases expression | 15890375 14600272
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of NRG1 mRNA | affects expression | 17562736
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 results in increased expression of NRG1 mRNA | increases expression | 14600272 15890375
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of NRG1 mRNA | affects expression | 16483693
|
C081565 |
arachidonyltrifluoromethane |
arachidonyltrifluoromethane inhibits the reaction [NRG1 protein alternative form results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15231676
|
C081565 |
arachidonyltrifluoromethane |
arachidonyltrifluoromethane inhibits the reaction [NRG1 protein alternative form results in increased phosphorylation of and results in increased activity of MAPK3 protein] | decreases reaction|increases activity|increases phosphorylation | 15231676
|
D001151 |
Arsenic |
Arsenic results in increased expression of NRG1 mRNA | increases expression | 19945496
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NRG1 mRNA | affects cotreatment|increases expression | 18164116
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NRG1 mRNA | decreases expression | 19150397
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of NRG1 mRNA | increases expression | 20382639
|
C070515 |
bisindolylmaleimide I |
bisindolylmaleimide I inhibits the reaction [NRG1 protein alternative form results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 15231676
|
C070515 |
bisindolylmaleimide I |
bisindolylmaleimide I inhibits the reaction [NRG1 protein alternative form results in increased phosphorylation of and results in increased activity of MAPK3 protein] | decreases reaction|increases activity|increases phosphorylation | 15231676
|
D002101 |
Cacodylic Acid |
Cacodylic Acid results in increased expression of NRG1 mRNA | increases expression | 17720352
|
C105934 |
celecoxib |
celecoxib inhibits the reaction [IL1B protein results in increased expression of and results in increased secretion of NRG1 protein] | decreases reaction|increases expression|increases secretion | 16357062
|
C105934 |
celecoxib |
celecoxib inhibits the reaction [IL1B protein results in increased expression of NRG1 mRNA] | decreases reaction|increases expression | 16357062
|
C105934 |
celecoxib |
Dinoprostone inhibits the reaction [celecoxib inhibits the reaction [IL1B protein results in increased expression of NRG1 mRNA]] | decreases reaction|increases expression | 16357062
|
D003024 |
Clozapine |
Clozapine results in increased expression of NRG1 mRNA | increases expression | 19502011
|
D003024 |
Clozapine |
NRG1 protein affects the susceptibility to Clozapine | affects response to substance | 15706234
|
D003024 |
Clozapine |
Clozapine affects the expression of NRG1 protein | affects expression | 18184445
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of NRG1 mRNA | increases expression | 20106945
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of NRG1 mRNA | affects cotreatment|increases expression | 18164116
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in increased expression of NRG1 mRNA | increases expression | 15890375
|
D004128 |
Dimethylnitrosamine |
Dimethylnitrosamine results in increased expression of NRG1 mRNA | increases expression | 14600272 15890375
|
C547156 |
dimethylthioarsinic acid |
dimethylthioarsinic acid results in decreased expression of NRG1 mRNA | decreases expression | 19945496
|
D004317 |
Doxorubicin |
NRG1 protein affects the reaction [Doxorubicin affects the phosphorylation of AKT1 protein] | affects phosphorylation|affects reaction | 15833803
|
D004317 |
Doxorubicin |
NRG1 protein affects the reaction [Doxorubicin affects the phosphorylation of ERBB2 protein] | affects phosphorylation|affects reaction | 15833803
|
D004317 |
Doxorubicin |
NRG1 protein affects the reaction [Doxorubicin affects the phosphorylation of MAPK1 protein] | affects phosphorylation|affects reaction | 15833803
|
D004317 |
Doxorubicin |
NRG1 protein affects the reaction [Doxorubicin affects the phosphorylation of MAPK3 protein] | affects phosphorylation|affects reaction | 15833803
|
D004317 |
Doxorubicin |
NRG1 protein affects the reaction [Doxorubicin affects the phosphorylation of RPS6KB1 protein] | affects phosphorylation|affects reaction | 15833803
|
D004317 |
Doxorubicin |
Doxorubicin results in increased expression of NRG1 protein alternative form | increases expression | 17308081
|
D004317 |
Doxorubicin |
NRG1 protein alternative form inhibits the reaction [Doxorubicin results in decreased expression of ATP2A2 protein] | decreases expression|decreases reaction | 17005195
|
D004317 |
Doxorubicin |
NRG1 protein alternative form inhibits the reaction [Doxorubicin results in decreased expression of GSR mRNA] | decreases expression|decreases reaction | 17005195
|
D004958 |
Estradiol |
Estradiol results in decreased expression of NRG1 mRNA | decreases expression | 20068009
|
D005472 |
Fluorouracil |
NRG1 protein affects the susceptibility to Fluorouracil | affects response to substance | 16217747
|
C056507 |
gemcitabine |
gemcitabine results in increased expression of NRG1 mRNA | increases expression | 17039268
|
D005947 |
Glucose |
MAPK1 protein promotes the reaction [NRG1 protein results in increased transport of Glucose] | increases reaction|increases transport | 14711829
|
D005947 |
Glucose |
MAPK3 protein promotes the reaction [NRG1 protein results in increased transport of Glucose] | increases reaction|increases transport | 14711829
|
D005947 |
Glucose |
[NRG1 protein binds to ERBB3 protein] which results in increased transport of Glucose | affects binding|increases transport | 14711829
|
D005947 |
Glucose |
NRG1 protein results in increased transport of Glucose | increases transport | 14711829
|
D005947 |
Glucose |
PDK1 protein promotes the reaction [NRG1 protein results in increased transport of Glucose] | increases reaction|increases transport | 14711829
|
D005947 |
Glucose |
PRKCZ protein promotes the reaction [NRG1 protein results in increased transport of Glucose] | increases reaction|increases transport | 14711829
|
D005947 |
Glucose |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [NRG1 protein results in increased transport of Glucose] | decreases reaction|increases transport | 14711829
|
D006220 |
Haloperidol |
Haloperidol results in increased expression of NRG1 protein | increases expression | 18184445
|
D006861 |
Hydrogen Peroxide |
NRG1 protein alternative form inhibits the reaction [Hydrogen Peroxide results in decreased expression of ATP2A2 protein] | decreases expression|decreases reaction | 17005195
|
D007649 |
Ketamine |
Ketamine results in decreased expression of NRG1 mRNA | decreases expression | 20000043
|
D008701 |
Methapyrilene |
Methapyrilene results in increased expression of NRG1 mRNA | increases expression | 15890375
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in increased expression of NRG1 mRNA | increases expression | 17616710
|
D010126 |
Ozone |
Ozone results in increased expression of NRG1 mRNA | increases expression | 16716893
|
C093973 |
PD 98059 |
NRG1 protein alternative form inhibits the reaction [PD 98059 results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 15231676
|
C093973 |
PD 98059 |
NRG1 protein alternative form inhibits the reaction [PD 98059 results in decreased phosphorylation of and results in decreased activity of MAPK3 protein] | decreases activity|decreases phosphorylation|decreases reaction | 15231676
|
D010656 |
Phenylephrine |
Phenylephrine results in decreased expression of NRG1 mRNA | decreases expression | 16698793
|
D010656 |
Phenylephrine |
Phenylephrine results in decreased expression of NRG1 protein | decreases expression | 16698793
|
D010882 |
Piperonyl Butoxide |
Piperonyl Butoxide results in increased expression of NRG1 mRNA | increases expression | 15890375
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of NRG1 mRNA | decreases expression | 17950772
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in decreased expression of NRG1 mRNA] | decreases expression|increases reaction | 17950772
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of NRG1 mRNA | increases expression | 15890375
|
D015232 |
Dinoprostone |
Dinoprostone inhibits the reaction [celecoxib inhibits the reaction [IL1B protein results in increased expression of NRG1 mRNA]] | decreases reaction|increases expression | 16357062
|
D015232 |
Dinoprostone |
Dinoprostone results in increased expression of NRG1 mRNA | increases expression | 16357062
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [NRG1 protein alternative form results in increased expression of MMP9 protein] | decreases reaction|increases expression | 17651959
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [NRG1 protein alternative form results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17651959
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [NRG1 protein alternative form results in increased phosphorylation of MAPK3 protein] | decreases reaction|increases phosphorylation | 17651959
|
C059514 |
resveratrol |
resveratrol results in decreased expression of NRG1 mRNA | decreases expression | 12002526
|
C115461 |
SC 560 |
SC 560 results in decreased expression of NRG1 mRNA | decreases expression | 14633654
|
C410733 |
scriptaid |
scriptaid affects the expression of NRG1 mRNA | affects expression | 18813790
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of NRG1 mRNA | increases expression | 19933214
|
D014108 |
Tosylphenylalanyl Chloromethyl Ketone |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [NRG1 protein results in increased transport of Glucose] | decreases reaction|increases transport | 14711829
|
D014303 |
Trinitrotoluene |
Trinitrotoluene affects the expression of NRG1 mRNA | affects expression | 21346803
|
C113580 |
U 0126 |
NRG1 protein alternative form inhibits the reaction [U 0126 results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] | decreases activity|decreases phosphorylation|decreases reaction | 15231676
|
C113580 |
U 0126 |
NRG1 protein alternative form inhibits the reaction [U 0126 results in decreased phosphorylation of and results in decreased activity of MAPK3 protein] | decreases activity|decreases phosphorylation|decreases reaction | 15231676
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of NRG1 mRNA | increases expression | 19101580
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
11.49 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Trinitrotoluene |
11.49 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
11.49 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.49 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.07 | 18287403 |
MESH:D000168 |
Acrocephalosyndactylia |
|
U 0126 |
5.00 | 17694057 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.42 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.67 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Dimethylnitrosamine |
9.00 | 16033868 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
9.00 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
9.00 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
9.00 | 17638652 |
MESH:D000236 |
Adenoma |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
17.91 | 16176798 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
17.91 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
17.91 | 6695378 10737359 |
MESH:D000236 |
Adenoma |
|
Dimethylnitrosamine |
17.91 | 19555203 |
MESH:D000236 |
Adenoma |
|
resveratrol |
17.91 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
14.46 | 19061943 18056438 17620307 17162532 19052882 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
14.46 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
14.46 | 16835633 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
celecoxib |
9.08 | 16215675 19003578 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Dinoprostone |
9.08 | 17942926 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
4.72 | 17306315 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
4.58 | 14617031 12649775 16160616 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.08 | 21441931 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
3.94 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
3.94 | 16162502 16183991 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.74 | 17688650 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
4.02 | 15469931 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
7.28 | 16511603 15504547 17963324 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
7.28 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.35 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.19 | 17497229 |
MESH:D001014 |
Aortic Aneurysm |
|
Dinoprostone |
5.14 | 10231640 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Dinoprostone |
5.15 | 10388637 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
3.69 | 17460149 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.71 | 18414634 16251483 16835338 12569548 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
7.10 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tosylphenylalanyl Chloromethyl Ketone |
7.10 | 18706406 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.43 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.48 | 17854713 16373670 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
5.89 | 19371607 12928151 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
5.89 | 16873680 17967414 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.10 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
2.10 | 18080171 19368416 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.10 | 15238991 16609825 20603192 18775368 18316065 18940202 17688650 17157402 17507914 19232924 18558336 18396377 18177632 19460635 18985861 |
MESH:D001477 |
Bartter Syndrome |
|
Dinoprostone |
5.26 | 15976003 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.81 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
7.32 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.32 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.29 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
6.95 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
6.95 | 8888407 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.20 | 14601052 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.06 | 15306635 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
3.80 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.39 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
6.32 | 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Cacodylic Acid |
6.32 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
6.32 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
6.32 | 17129689 15324884 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
6.32 | 18234424 15692762 16264153 16322301 16096432 16935488 18628466 17983394 18695136 16595493 19526202 11325840 16826403 15136595 16115903 15634643 15993339 18382427 17369602 17426702 15567936 15994142 15668708 15939500 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
6.32 | 19861407 17261762 12948864 16675129 17289903 17018787 18497071 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
6.32 | 18357371 16595493 19217205 16557594 18608205 15136595 16110121 |
MESH:D001943 |
Breast Neoplasms |
|
gemcitabine |
6.32 | 18382427 17039268 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
6.32 | 16393696 17534123 17651959 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
6.32 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.29 | 16777450 14754758 17626835 18417511 15516495 18315731 19059883 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.25 | 16183385 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.98 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
10.70 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
10.70 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Dimethylnitrosamine |
11.76 | 19555203 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
11.76 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
11.76 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.30 | 15504454 17687452 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
26.82 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
26.82 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
26.82 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
26.82 | 21507988 12619106 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
26.82 | 16507464 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
26.82 | 20727157 19519916 18788625 16807293 16569478 11831363 19418558 20432363 18210153 19822196 19701751 18056438 18971187 17138121 19919837 20935162 10737359 18494052 20214788 20084675 19383236 20101231 10672840 18506893 19107877 17428255 3084413 20524982 18665156 19335982 16935385 21159647 19208518 19394651 18393292 16681979 16502159 17162532 16328049 17978847 16878318 17173139 17055752 17761372 20512989 16779866 20514400 16540662 19052882 18691550 19539802 20007298 18978308 19171122 16698587 16288022 16830150 18785209 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
26.82 | 15948411 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
26.82 | 16234567 18059187 17876044 16023760 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
26.82 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
26.82 | 18930000 17971768 16799960 16332177 17045692 17088986 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
26.82 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
SC 560 |
26.82 | 16391822 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.11 | 16675471 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
celecoxib |
9.54 | 16369983 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
9.54 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
9.54 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
12.57 | 15504454 18922899 17687452 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Dimethylnitrosamine |
12.57 | 16033868 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
12.57 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
12.57 | 17066447 16757204 18986760 16280240 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
12.57 | 16227395 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
3.66 | 18640142 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
5.93 | 11179087 17124262 16170337 15728586 17287366 11754973 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
5.93 | 16120746 18670907 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.20 | 15505089 18627295 16612575 16242529 16278810 16731534 17924179 16269455 16952015 16364871 15811867 15476868 16109756 17351982 17974986 16651473 17382496 17519947 15792986 17131338 17007740 17308081 17928571 17329180 16455267 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.76 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
10.29 | 15738583 19152805 17938729 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
10.29 | 16936243 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
10.29 | 15458977 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
3.90 | 16973168 18022660 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
4.42 | 1977408 15215559 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
6.51 | 10977129 |
MESH:D002386 |
Cataract |
|
Trinitrotoluene |
6.51 | 14694615 15817613 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
21.92 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
21.92 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
21.92 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
21.92 | 17174075 21159647 2727394 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Dinoprostone |
21.92 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
21.92 | 18566989 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.52 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
7.96 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
7.96 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
6.54 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
6.54 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.89 | 12621046 8697196 16354765 15668235 15340226 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
4.49 | 17123785 |
MESH:D003092 |
Colitis |
|
resveratrol |
3.66 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
celecoxib |
5.38 | 16004971 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
5.38 | 17287894 17725105 17169374 16510598 17018589 15001691 17172411 18772588 16340194 17016597 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
5.38 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
celecoxib |
4.40 | 11197048 18349538 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
4.40 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
4.40 | 17094418 18383874 17454858 16331619 17401013 18802399 17016601 16282729 17594712 20501625 14970324 16524972 17255274 17695437 15148649 15289873 18448328 16303861 16391804 18288408 18509181 18949393 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
4.40 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
7.91 | 17141729 14669216 |
MESH:D000013 |
Congenital Abnormalities |
|
Trinitrotoluene |
7.91 | 15095906 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.43 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.30 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.30 | 16575769 8888407 17688650 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
4.09 | 16002989 12952375 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
16.05 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
16.05 | 18551238 |
MESH:D003490 |
Cyanosis |
|
Trinitrotoluene |
16.05 | 18551238 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.30 | 16733453 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
4.39 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
4.14 | 11575062 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.18 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.37 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
6.32 | 16402076 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
6.32 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.32 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
7.66 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
7.66 | 16286809 |
MESH:D003967 |
Diarrhea |
|
Dinoprostone |
4.10 | 10446763 7237001 11488427 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
5.06 | 15331141 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
22.52 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
22.52 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
22.52 | 18071297 15619225 11739529 16109766 19923254 16781746 14550746 12392966 12594235 15968718 2444490 11287661 10774834 19085960 11461765 11421492 12540782 12705907 19416960 14725611 16393943 19739265 18713872 17906064 11529661 16081117 19370779 17522070 12153990 19420014 17562736 14986274 11743745 10915739 16485898 16227642 10663392 16177239 19164858 11834606 12958197 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
22.52 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Dimethylnitrosamine |
22.52 | 8172417 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
22.52 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
22.52 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Trinitrotoluene |
22.52 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
22.52 | 1733752 19641884 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.60 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
6.90 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
6.90 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
3.83 | 16402076 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.60 | 1851702 |
MESH:D004487 |
Edema |
|
bisindolylmaleimide I |
12.96 | 8273558 |
MESH:D004487 |
Edema |
|
pirinixic acid |
12.96 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
12.96 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
12.96 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.41 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
3.57 | 17872969 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
4.21 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
10.62 | 16804899 15700306 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
10.62 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
10.62 | 19148513 11473722 18566989 |
MESH:D004715 |
Endometriosis |
|
celecoxib |
7.96 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
7.96 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.66 | 18037988 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.37 | 17923197 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.68 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.42 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.67 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.18 | 6254150 7562514 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
3.82 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.58 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.62 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
9.21 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Dimethylnitrosamine |
9.21 | 17016578 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
9.21 | 16481741 17638652 16785472 16337965 15173087 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
9.21 | 15547733 15547721 15264214 15150132 16510608 15623463 16704527 16805852 15878914 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.65 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
15.20 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
15.20 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
15.20 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
15.20 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
3.35 | 16534752 16513791 15751030 16611131 16002989 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.98 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.39 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.67 | 8888407 18558336 |
MESH:D005334 |
Fever |
|
Dinoprostone |
4.46 | 16997862 11852909 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.10 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
6.91 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
6.91 | 20067830 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.06 | 6392382 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.18 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
4.46 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.73 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.03 | 17150277 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.66 | 16145905 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.10 | 10696789 |
MESH:D006261 |
Headache |
|
Ketamine |
5.52 | 11554966 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
6.80 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
6.80 | 15162350 18337622 15102660 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.06 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.14 | 16244371 16495754 16244372 16144979 18006777 16707910 16879835 12587719 14766674 16330681 17875725 17888722 18674790 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
6.01 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.01 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.47 | 15692506 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.93 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.90 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
11.74 | 19176532 16221962 19772884 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
11.74 | 16120746 15340226 12621046 |
MESH:D006529 |
Hepatomegaly |
|
Trinitrotoluene |
11.74 | 15817613 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.53 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.70 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.01 | 18501091 17606976 15147373 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.26 | 17088409 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.38 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.55 | 8697196 16959395 15340226 16354765 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
6.83 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Dinoprostone |
6.83 | 16793879 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.57 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.76 | 20558911 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.03 | 17050553 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
4.42 | 16046005 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.58 | 16873680 |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
3.96 | 14722030 12960047 |
MESH:D006973 |
Hypertension |
|
Arsenic |
10.67 | 9931084 11953799 16076760 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
10.67 | 10903974 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
10.67 | 12717712 8949925 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
10.67 | 18850075 18670907 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.12 | 12791704 18502941 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.88 | 17488730 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.06 | 16093927 |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
4.10 | 16002989 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.17 | 17600658 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
3.89 | 15036965 |
MESH:D007248 |
Infertility, Male |
|
Trinitrotoluene |
3.35 | 12150543 |
MESH:D007249 |
Inflammation |
|
bisindolylmaleimide I |
9.81 | 8273558 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
9.81 | 18785209 |
MESH:D007249 |
Inflammation |
|
resveratrol |
9.81 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
9.81 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.05 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.10 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.10 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
2.90 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.94 | 15604871 |
MESH:D007642 |
Keratosis |
|
Arsenic |
4.50 | 12749816 16930632 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
12.00 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
12.00 | 10903974 8314463 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
12.00 | 15369732 16775033 15699352 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
12.00 | 15618244 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
8.68 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
8.68 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
23.96 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
23.96 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
23.96 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
23.96 | 16762066 14681315 15003126 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
23.96 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
23.96 | 16985049 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
3.59 | 17184923 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.66 | 16085563 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
PD 98059 |
10.47 | 16972261 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
U 0126 |
10.47 | 16972261 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.06 | 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
6.82 | 17339181 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
6.82 | 16087638 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
3.61 | 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.55 | 18522880 20032147 18665156 18407596 19638242 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dimethylnitrosamine |
7.74 | 18095165 12918455 15864749 15591649 15086199 14568256 15067225 15383259 17036385 18371158 15492853 17203207 16042886 16009107 18364076 18637143 15942678 15366600 17465448 15842777 17196135 17201889 15763062 15577212 17432682 15571005 16169303 15369754 16544323 18239293 14659978 18629640 17719030 14726149 15479170 17724770 15298665 15744066 18210741 17534399 14709902 15733078 17198567 16570917 17881167 18567088 15099470 15793283 17348192 15161499 15081153 15798949 18672772 15723089 18237412 14643895 15138612 15504291 17666798 12925901 15339415 16603200 16270385 17640959 16627068 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dinoprostone |
7.74 | 15816358 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
7.74 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
7.74 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
7.74 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
7.74 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
8.19 | 16611625 19784758 19014921 19460945 11587558 12969438 16610002 12587719 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
8.19 | 11134558 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
8.19 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Dinoprostone |
8.19 | 15816358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
8.27 | 16871587 17185352 |
MESH:D017114 |
Liver Failure, Acute |
|
Dimethylnitrosamine |
8.27 | 17457977 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
50.72 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
2-nitrofluorene |
50.72 | 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
50.72 | 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
50.72 | 9163691 2125692 15890375 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
50.72 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
50.72 | 19389873 21295105 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
50.72 | 19551842 9163691 19690152 19996281 20434301 20405173 18977376 20583210 19294768 19073162 20118626 19833225 18644402 21047994 19850985 20492335 15175105 18978307 2422723 19812893 19090486 15885732 19254457 16942905 19426721 12771043 20101389 10737359 18754104 20137499 18648771 19427195 19499222 19638242 19256749 20501860 2862719 20452335 12112319 19255062 21167192 19642983 21071580 21278145 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
50.72 | 15890375 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Dimethylnitrosamine |
50.72 | 15890375 3113478 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
50.72 | 15113037 16603448 18383874 17045692 |
MESH:D008113 |
Liver Neoplasms |
|
Methapyrilene |
50.72 | 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Piperonyl Butoxide |
50.72 | 19690152 20101389 18648771 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
50.72 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
50.72 | 19321006 19073162 20405173 19812893 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
50.72 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
23.43 | 6135515 2876786 2876784 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
23.43 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
23.43 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
23.43 | 9362446 2563599 19519916 18775883 18253720 17854601 16842330 21159647 18282651 16267830 17942915 19539802 18544905 17174075 18164116 19009564 18079962 18093689 18308698 3124819 19126423 19004024 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Dimethylnitrosamine |
23.43 | 6150874 1848544 15603536 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
23.43 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
23.43 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
3.04 | 19066396 8266340 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
3.77 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.38 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
13.86 | 18508827 16061637 15893417 17139156 18813816 12438228 19931552 9255578 14755239 16401635 15172992 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
13.86 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
13.86 | 17306315 17976673 19168569 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
13.86 | 20970405 21163286 20512841 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Dimethylnitrosamine |
13.86 | 16061637 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
13.86 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
13.86 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
13.86 | 7614698 8597069 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
13.86 | 11884234 19555203 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.30 | 15086387 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
4.66 | 15166399 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
6.57 | 15700306 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
6.57 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
3.85 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
7.56 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
7.56 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.09 | 15621674 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
5.02 | 16002989 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
3.76 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
celecoxib |
11.71 | 19196722 12104042 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
11.71 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
11.71 | 11807958 16891317 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
11.71 | 11606380 8985016 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
3.99 | 19453300 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
4.73 | 16827129 |
MESH:D008545 |
Melanoma |
|
Glucose |
4.73 | 14993021 |
MESH:D008545 |
Melanoma |
|
resveratrol |
4.73 | 17992120 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.09 | 19513568 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
6.77 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
6.77 | 16856516 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
2.85 | 17638057 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.94 | 17112576 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
4.01 | 19142101 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.29 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.61 | 10496685 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
2.84 | 18765137 18803445 |
MESH:D020326 |
Migraine without Aura |
|
Dinoprostone |
4.80 | 11304026 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.06 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.26 | 18986760 16757204 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.30 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
celecoxib |
6.73 | 16123214 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
6.73 | 17049120 14749477 17935668 16490592 16267019 17164350 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.38 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.03 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.59 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
2.86 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
8.20 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
8.20 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
8.20 | 17188708 16317513 16525036 17125593 16456233 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
13.06 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
13.06 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
13.06 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.00 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.00 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.27 | 17322642 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
14.97 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
14.97 | 18551238 7678174 |
MESH:D009336 |
Necrosis |
|
Trinitrotoluene |
14.97 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
5.16 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
5.16 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
6.79 | 15313581 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
6.79 | 18600527 16928823 18239605 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
6.79 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
3.53 | 8985016 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
celecoxib |
4.94 | 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.25 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.29 | 16636307 16899518 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.94 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
7.93 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
7.93 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
13.71 | 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
13.71 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
13.71 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
6.36 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
6.36 | 16359493 8888407 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.00 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
11.75 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
11.75 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
11.75 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
9.21 | 17056641 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
9.21 | 17929310 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.62 | 20387270 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.10 | 16436463 |
MESH:D009765 |
Obesity |
|
Clozapine |
4.22 | 18515891 19142110 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.22 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
12.74 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
12.74 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
Trinitrotoluene |
12.74 | 17852074 12819281 14694615 |
MESH:D010005 |
Osteoarthropathy, Secondary Hypertrophic |
|
Dinoprostone |
5.98 | 18500342 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
3.81 | 17513867 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.72 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
7.02 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
7.02 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
U 0126 |
7.02 | 16211241 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.01 | 16870215 |
MESH:D010149 |
Pain, Postoperative |
|
Ketamine |
5.63 | 11554966 |
MESH:D010190 |
Pancreatic Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
10.79 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
10.79 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
10.79 | 19003803 16929163 15113037 16500647 |
MESH:D010190 |
Pancreatic Neoplasms |
|
gemcitabine |
10.79 | 11504793 18992248 18383843 16929163 17440100 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
3.62 | 12065085 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.75 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
3.72 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
4.50 | 6392382 15371236 16905509 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.66 | 16369182 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.66 | 17983394 |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
4.67 | 14722030 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
4.19 | 15687265 16977796 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.66 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Ozone |
3.91 | 18381685 18929643 18007984 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.10 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
7.58 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
7.58 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
19.27 | 17184923 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
19.27 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
19.27 | 11896295 11118676 11399792 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
19.27 | 20603192 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.45 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
2.02 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
celecoxib |
2.02 | 15570007 17908994 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
2.02 | 15846301 15046698 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.02 | 18437689 15897917 15749863 16729912 16868541 16888761 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.02 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.02 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.02 | 17718901 15767336 17636462 17675339 17804756 16731767 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
3.56 | 21343184 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.04 | 11422049 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.04 | 16882103 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
4.48 | 11575062 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
7.97 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
7.97 | 11575062 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.60 | 18286688 15538739 16160472 18722050 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
3.75 | 17922066 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.09 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
5.71 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
5.71 | 15827377 16314181 16317513 17058453 17520802 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.37 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
3.72 | 19155313 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.57 | 17710206 16767912 18313854 15625365 17203757 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
3.78 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.30 | 17846226 |
MESH:D012559 |
Schizophrenia |
marker/mechanism |
|
| 12145742 17460065 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
7.25 | 20452607 17726453 18806925 16141801 18855531 20168265 11763009 17667964 20521326 19369910 20107430 17123785 20580759 20521320 11151749 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
7.25 | 18513383 1830565 20107430 19369910 |
MESH:D012559 |
Schizophrenia |
|
Ketamine |
7.25 | 20000043 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
7.25 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
11.32 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
11.32 | 18551238 |
MESH:D012640 |
Seizures |
|
Trinitrotoluene |
11.32 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
11.32 | 3137016 17978042 1511512 16876388 15475178 11738929 14763951 11044598 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.22 | 7327846 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.61 | 17453740 18709164 16702368 19834688 17548696 17938729 15952646 16759981 16353154 17050553 6392382 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
19.25 | 17050553 15504454 16251483 19538983 17029826 17976673 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
19.25 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Glucose |
19.25 | 14993021 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
19.25 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
19.25 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
19.25 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.09 | 16767912 17203757 15625365 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
4.22 | 16002989 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.40 | 19490988 |
MESH:D013158 |
Splenic Diseases |
|
Dimethylnitrosamine |
4.77 | 12587719 |
MESH:D013163 |
Splenomegaly |
|
Trinitrotoluene |
4.72 | 15817613 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.04 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
celecoxib |
5.76 | 15609394 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
5.76 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Dimethylnitrosamine |
5.76 | 16033868 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
5.76 | 19015929 18396642 16424979 18567086 15786421 19084572 17498489 16951190 17522103 17172411 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
5.76 | 12958204 17575124 |
MESH:D013276 |
Stomach Ulcer |
marker/mechanism |
|
| 16357062 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.05 | 16321402 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
4.25 | 20210726 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.41 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
6.06 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
6.06 | 16010429 17909728 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.19 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
8.58 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
8.58 | 16227395 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.74 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.03 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
17.11 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
17.11 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
17.11 | 11144890 15987713 19322015 19429237 17976673 18640142 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cacodylic Acid |
17.11 | 15537745 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
17.11 | 17306315 16452187 16712894 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
17.11 | 17653716 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.17 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
10.37 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
10.37 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.53 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
13.51 | 16175088 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
13.51 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
13.51 | 17473185 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
4.67 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
celecoxib |
13.64 | 18645019 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
13.64 | 15809267 16690809 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
13.64 | 17044934 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.49 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
3.96 | 16002989 16513791 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
4.25 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.10 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
8.76 | 17334414 16364871 17678736 17638931 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
8.76 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.75 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
4.06 | 16402076 16141801 17502770 20521320 20564506 20107430 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
4.59 | 17933447 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.94 | 17120751 |